ALNEV.PA

Neovacs S.A.
ParisEUREQUITY DELAYED
Last price
0.62
▼ 0.06 (8.53%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
0.69
Prev close
0.68
Day high
0.69
Day low
0.62
Volume
38.15K
Market cap
P/E (TTM)
52W range
0.61 – 7,900.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-10.54% -9.2%
1M
-24.44% -28.2%
3M
-69.40% -72.5%
6M
-96.40% -107.5%
YTD
-99.30% -111.6%
1Y
-99.99% -120.0%
3Y
-100.00% -174.2%
5Y
-100.00%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on ALNEV.PA open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 1 quarters
Blank means not reported, not zero
Line item2024202320222021YoY
Total revenue $366.35K$534.27K$2.48K$22.59K -31.4%
Operating revenue $366.35K$534.27K$2.48K$22.59K -31.4%
Cost of revenue $323.93K$504.10K$577.41K$484.90K -35.7%
Gross profit $42.42K$30.17K-$574.93K-$462.31K +40.6%
Selling, general & admin $4.08M
Total operating expense $13.71M$12.35M$6.20M$7.43M +11.1%
Operating income -$13.67M-$12.32M-$6.78M-$7.89M -11.0%
Net interest income -$19.24M$3.19M$3.63M-$1.81M -703.9%
Pre-tax income -$33.95M-$9.62M-$4.35M-$12.48M -252.9%
Tax provision -$1.03M-$876.76K-$797.44K-$641.05K -17.9%
Net income -$32.91M-$8.74M-$3.55M-$11.84M -276.4%
Net income to common -$32.91M-$8.74M-$3.55M-$11.84M -276.4%
Basic EPS -221.36-249,812.86-1,182,834.33-47,731.06 +99.9%
Diluted EPS -221.36-249,812.86-1,182,834.33-47,731.06 +99.9%
EBIT -$33.95M-$9.62M-$4.35M-$12.48M -252.9%
EBITDA -$26.13M-$4.05M-$3.86M-$12.32M -545.4%
Basic shares 269.59K353248 +770,157.1%
Diluted shares 269.59K353248 +770,157.1%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
0.79
-21.04% from price
SMA 20
0.79
-22.49% from price
SMA 50
1.14
-46.49% from price
SMA 100
2.00
-68.93% from price
SMA 200
41.48
-98.52% from price
EMA 12
0.75
-17.53% from price
EMA 26
0.88
-29.28% from price
EMA 50
4.22
-85.27% from price
RSI (14)
38.0
Neutral
MACD (12,26,9)
-0.13
Hist 0.01
ATR (14)
0.17
27.74% of price
Realised vol 30D
214.9%
Annualised
Bollinger upper
1.11
20, 2σ
Bollinger lower
0.47
20, 2σ
50 / 200 cross
Death
1.14 vs 41.48
Trend bias
Below 200
-98.52%

Options chain

Account required
ExpirySpot 0.62
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
1.81
More volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
214.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-100.0%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.17
27.74% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.